AVEO Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AVEO Pharmaceuticals generated cash of -$57,257,000, which is less than the previous year. Cash used in financing activities reached the amount of $82,904,000 last year. Net change in cash is therefore $8,781,000.
Cash Flow
| 2012 | -105.72M | 135.24M | 3.13M |
|---|---|---|---|
| 2013 | -84.40M | 12.07M | 46.99M |
| 2014 | -54.24M | 54.71M | 1.01M |
| 2015 | -18.23M | -6.31M | -1.12M |
| 2016 | -31.06M | -764K | 20.29M |
| 2017 | -19.16M | -10.40M | 29.41M |
| 2018 | -25.02M | 18.57M | 15.92M |
| 2019 | -2.91M | -17.91M | 26.19M |
| 2020 | -37.98M | 17.70M | 52.25M |
| 2021 | -57.25M | -16.86M | 82.90M |
AVEO Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 61.76M | 29.78M | 24.42M | 14.94M | 15.09M | 26.63M | 52.30M | 50.82M | 76.13M | 43.50M |
Operating activities | ||||||||||
Net income | -53.34M | -35.58M | 9.38M | -5.32M | -65.02M | -26.88M | -15.00M | -52.73M | -107.02M | -114.39M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 145K | 21K | 0 | 3K | 0 | 30K | 9.56M | 6.21M | 3.77M | 2.51M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.94M | 8.00M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.94M | 8.00M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -9.81M | 433K | 1.39M | -2.62M | 625K | 3.61M | -2.3M | -1.35M | 19.66M | -13.43M |
Inventories | -1.65M | -684K | -1.67M | -1.03M | 6.88M | -3.82M | -6.33M | 10.30M | -7.22M | 0 |
Accounts payable | -667K | 1.91M | -2.03M | 1.06M | 250K | 760K | -1.82M | -993K | -6.39M | 1.72M |
Cash generated by operating activities | -57.25M | -37.98M | -2.91M | -25.02M | -19.16M | -31.06M | -18.23M | -54.24M | -84.40M | -105.72M |
Investing activities | ||||||||||
Purchases Of Investments | -28.16M | -36.13M | -17.91M | -6.73M | -34.85M | -29.42M | -19.08M | -42.30M | -175.39M | -194.58M |
Investments In Property Plant And Equipment | 0 | -363K | 0 | 0 | 0 | -7K | -22K | -12.94M | -3.66M | -9.94M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 764K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -16.86M | 17.70M | -17.91M | 18.57M | -10.40M | -764K | -6.31M | 54.71M | 12.07M | 135.24M |
Financing activities | ||||||||||
Common Stock Issued | 55.09M | 53.67M | 30.32M | 16.46M | 24.51M | 15.40M | 10.48M | 191K | 54.10M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -6.49M | 0 | 0 | 0 | 0 | 0 | -7.78M | -7.10M | -2.17M |
Cash used in financing activities | 82.90M | 52.25M | 26.19M | 15.92M | 29.41M | 20.29M | -1.12M | 1.01M | 46.99M | 3.13M |
Net Change In Cash | 8.78M | 31.97M | 5.35M | 9.47M | -147K | -11.53M | -25.67M | 1.48M | -25.30M | 32.62M |
Cash at end of period | 70.54M | 61.76M | 29.78M | 24.42M | 14.94M | 15.09M | 26.63M | 52.30M | 50.82M | 76.13M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |